Cervical cytology associated with levonorgestrel contraception

Area of Science:

• Gynecology
• Oncology
• Family Planning

Background:

• Cervical cancer screening is crucial for women's health.
• Levonorgestrel contraception is widely used, necessitating safety assessments.
• Understanding the impact of hormonal contraceptives on cervical cytology is important.

Purpose of the Study:

• To evaluate the safety of levonorgestrel contraception (implant vs. IUD) on cervical cytology.
• To assess the incidence and progression of cervical dysplasia during long-term use.
• To compare the effects of subdermal implants and intrauterine devices on cervical health.

Main Methods:

• Cytologic monitoring of cervical smears in 686 women using levonorgestrel implants or IUDs.
• Follow-up ranged from six months to five years.
• Comparison of pre- and post-insertion cytology with a control group.

Main Results:

• No cases of malignant neoplasia were observed.
• A 2.8% incidence of mild/moderate dysplasia was detected post-insertion, which was not statistically significant compared to controls (1.3%).
• All dysplastic lesions regressed to normal; none progressed to malignancy. The implant group showed a lower dysplasia incidence (2.1%) than the IUD group (4.9%).

Conclusions:

• Levonorgestrel implants appear safe regarding cervical pathology for up to five years.
• While IUDs showed a higher incidence of dysplasia, all lesions regressed.
• Further long-term studies with larger cohorts are recommended for definitive conclusions.